VRDN
Viridian Therapeutics, Inc. · Healthcare
CEO Scott Dunseth Myers bought $160K of Viridian Therapeutics, Inc.
Bought$160,324
$29.15Price
5,500Shares
+2%Stake
What VRDN did for a copier
- $1,000 copied at Mon, Mar 13 close, $28.85
- $978
- S&P 500, same days
- +5.8%
Measured over 30 trading days, to the Apr 25 close.
Scott Dunseth Myers's record
3 other buys with 3 months of prices since 2023: on average −12.9% against the S&P 500, and 1 of 3 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Mon, Mar 13. Filed Mon, Mar 13, 12:06 PM ET, during the session. Returns use the Mar 13 close and the Apr 25 close. Not investment advice.